omega-n-methylarginine has been researched along with Tuberculoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briscoe, H; Britton, WJ; Meadows, N; Rathjen, D; Roach, DR | 1 |
1 other study(ies) available for omega-n-methylarginine and Tuberculoma
| Article | Year |
|---|---|
A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Bone Marrow Cells; CD4-Positive T-Lymphocytes; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Humans; Immunologic Factors; Interferon-gamma; Lymphocyte Depletion; Macrophages; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Peptide Fragments; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Proteins; Recurrence; Specific Pathogen-Free Organisms; Tuberculoma; Tuberculosis; Tumor Necrosis Factor-alpha | 2000 |